Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Yunkang Group Ltd

2325
Current price
7.87 HKD -0.01 HKD (-0.13%)
Last closed 7.87 HKD
ISIN KYG9889T1067
Sector Healthcare
Industry Diagnostics & Research
Exchange Hong Kong Stock Exchange
Capitalization 4 673 212 368 HKD
Yield for 12 month -34.09 %
1Y
3Y
5Y
10Y
15Y
2325
21.11.2021 - 28.11.2021

Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests, including hepatitis B virus, tuberculosis, human papilloma virus, EB virus, rabies virus, and nucleic acid tests for respiratory pathogens; genetic reproduction, and screening tests. In addition, the company offers routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases. Further, it provides diagnostic testing services for financial institutions and insurance companies, including personalized diagnostic testing, medical report consultation, and hospital referral services; information technology, medical logistics, and medical equipment procurement; and healthcare technology development. The company provides its services through independent clinical laboratories and on-site diagnostic centers. Yunkang Group Limited was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China. Address: No. 9 Yayingshi Road, Guangzhou, China

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

102.13 HKD

P/E ratio

Dividend Yield

0.25 %

Current Year

+962 319 696 HKD

Last Year

+4 054 589 122 HKD

Current Quarter

+514 746 589 HKD

Last Quarter

Current Year

+351 666 050 HKD

Last Year

+1 411 614 511 HKD

Current Quarter

+196 096 253 HKD

Last Quarter

Key Figures 2325

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -193 700 474 HKD
Operating Margin TTM -29.69 %
PE Ratio
Return On Assets TTM -3.43 %
PEG Ratio
Return On Equity TTM -13.11 %
Wall Street Target Price 102.13 HKD
Revenue TTM 795 475 214 HKD
Book Value 3.21 HKD
Revenue Per Share TTM
Dividend Share 0.018 HKD
Quarterly Revenue Growth YOY -20.3 %
Dividend Yield 0.25 %
Gross Profit TTM 900 152 297 HKD
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY -82.1 %
Profit Margin -34.87 %

Dividend Analytics 2325

Dividend growth over 5 years

Continuous growth

1 year

Payout Ratio 5 years average

-53 %

Dividend History 2325

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.02
Ex Dividend Date 04.07.2024
Forward Annual Dividend Yield 0.26 %
Last Split Factor
Payout Ratio 93.73 %
Last Split Date
Dividend Date

Stock Valuation 2325

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 51.0204
Enterprise Value Revenue 5.1437
Price Sales TTM 5.8747
Enterprise Value EBITDA 189.1705
Price Book MRQ 2.2465

Financials 2325

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 2325

For 52 weeks

7.31 HKD 12.29 HKD
50 Day MA 8.56 HKD
Shares Short Prior Month
200 Day MA 9.99 HKD
Short Ratio
Shares Short
Short Percent